Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Single Center, Single Participant Study of an Experimental Antisense Oligonucleotide Treatment for PCARP (Posterior Column Ataxia With Retinitis Pigmentosa) Disease Due to Mutations in FLVCR1

NCT06565572 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT06565572
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06565572 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Single Center, Single Participant Study of an Experimental Antisense Oligonucleotide Treatment for PCARP (Posterior Column Ataxia With Retinitis Pigmentosa) Disease Due to Mutations in FLVCR1
Lead sponsor
University of Colorado, Denver
Phase
Phase 1
Overall status
Enrolling by invitation
Start date
August 23, 2023
Completion date
December 31, 2028
Enrollment
1 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

posterior column ataxia with retinitis pigmentosa